Myeloproliferative Disorder Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about Myeloproliferative Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Not Applicable

Feasibility of a Multi-omics Platform for Hematological Malignancies

Acute LeukemiaChronic LeukemiaLymphoproliferative Disorders+3 more
Azienda Ospedaliero-Universitaria di Parma1,040 enrolled1 locationNCT07445438
Recruiting
Not Applicable

Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)

Acute LeukemiaChronic LeukemiaLymphoproliferative Disorders+2 more
Azienda Ospedaliero-Universitaria di Parma250 enrolled1 locationNCT07445984
Recruiting
Not Applicable

INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

Pancreatic CancerOvarian CancerMelanoma+9 more
Azienda Ospedaliero-Universitaria di Parma300 enrolled2 locationsNCT07403630
Recruiting
Phase 1

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

Acute Myeloid LeukemiaLeukemiaMyelodysplastic Syndromes+3 more
Dana-Farber Cancer Institute15 enrolled2 locationsNCT06138587
Recruiting
Phase 1

Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft

Acute LeukemiaMyelodysplastic SyndromesMyeloproliferative Disorders+3 more
Stanford University60 enrolled1 locationNCT05088356
Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Breast CancerOvarian CancerEndometrial Cancer+40 more
Massive Bio, Inc.50,000 enrolled68 locationsNCT03452774
Recruiting

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

LymphomaLeukemiaMyelodysplastic Syndromes+5 more
UNC Lineberger Comprehensive Cancer Center15,000 enrolled1 locationNCT01137643
Recruiting
Phase 2

Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant

Myelodysplastic SyndromeAcute LeukemiaMyeloproliferative Disorders
University of Alabama at Birmingham56 enrolled1 locationNCT06265584
Recruiting
Phase 2

Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

Acute LeukemiaGVHD,AcuteMyelodysplastic Syndromes+1 more
University of Alabama at Birmingham29 enrolled1 locationNCT06315309
Recruiting
Not Applicable

I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients

LeukemiaMyeloproliferative Disorders
Massachusetts General Hospital30 enrolled3 locationsNCT05842603
Recruiting
Phase 2

Cord Blood Transplant in Adults With Blood Cancers

Non-Hodgkin's LymphomaAcute Myelogenous Leukemia (AML)Myelodysplastic Syndromes (MDS)+3 more
Memorial Sloan Kettering Cancer Center54 enrolled1 locationNCT05884333
Recruiting

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

LymphomaUnspecified Adult Solid Tumor, Protocol SpecificLeukemia+6 more
Barbara Ann Karmanos Cancer Institute1 locationNCT00935090
Recruiting

Registry of Older Patients With Cancer

LymphomaUnspecified Adult Solid Tumor, Protocol SpecificLeukemia+6 more
UNC Lineberger Comprehensive Cancer Center3,000 enrolled7 locationsNCT01137825
Recruiting
Phase 2

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

Hodgkin LymphomaNon-Hodgkin LymphomaMultiple Myeloma+7 more
University of Liege114 enrolled10 locationsNCT03852407